Pfizer (PFE) Stock Surges to 52-Week Peak Following Strong Q2 Results and Major Legal Settlement
Pfizer (PFE) stock touched a 52-week high of $29.09 after Q2 earnings exceeded forecasts and the company settled over 6,000 Depo-Provera lawsuits.
The post Pfizer (PFE) Stock Surges to 52-Week Peak Following Strong Q2 Results and Major Legal Settlement appeared first on Blockonomi.
Source: Source: Blockonomi